Gary Peltz, Head of Genetics & Genomics at Roche Palo Alto to Give Keynote Talk on Computational Genetics at PK/PD Track of 3rd Modern Drug Discovery & Development Summit
Gary Peltz, Head of Genetic/Genomics at Roche to give keynote presentation at PK/PD track at 3rd Modern Drug Discovery & Development Summit on November 28-30, 2007 in San Francisco.
Monrovia, CA, October 26, 2007 --(PR.com)-- Dr. Gary Peltz, the Head of Genetics and Genomics at Roche in Palo Alto, CA will give the keynote presentation on “Computational Genetics: Toward Understanding our Drugs and Diseases” at the Pharmaco – Kinetics, Dynamics, Genetics and Genomics track at the 3rd Modern Drug Discovery & Development Summit on November 28-30, 2007 at the Hyatt Regency San Francisco Airport.
The understanding of genetic factors effecting human disease susceptibility and drug response is advanced by analysis of murine genetic models. Roche developed a novel computational method that identifies a causative genetic factor by correlating a pattern of observable physiological or pathological differences among selected strains of mice with the pattern of genetic variation. This computational method correctly predicted the genetic basis for strain-specific differences in multiple biologically important phenotypic traits, including drug metabolism and drug response. Of clinical interest, genetic factors affecting narcotic drug withdrawal and susceptibility to fungal infection in transplant patients were also identified using this method.
Dr. Peltz, along with over 150 leading industry executives, will present at the 3rd Modern Drug Discovery & Development Summit. The summit features 6 concurrent conferences, 6 study sessions and 3 workshops. Tracks include Biological Therapeutics, Drug Delivery Technology, Translational Medicine, Drug Design and Lead Optimization, Emerging Targets, and Pharmaco – Kinetics, Dynamics, Genetics & Genomics. For more information, visit www.gtcbio.com.
About GTCbio
GTCbio organizes conferences specifically for the biomedical and biopharmaceutical industries. Their goal is to facilitate the exchange of biopharmaceutical and biomedical intelligence between industry leaders, academic and government organizations, and the financial community.
GTCbio is a subsidiary of Global Technology Community, LLC, a privately held company founded in 2002.
Contact: GTCBIO (626) 256-6405, (626) 256-6460 fax, raniah@gtcbio.com
###
The understanding of genetic factors effecting human disease susceptibility and drug response is advanced by analysis of murine genetic models. Roche developed a novel computational method that identifies a causative genetic factor by correlating a pattern of observable physiological or pathological differences among selected strains of mice with the pattern of genetic variation. This computational method correctly predicted the genetic basis for strain-specific differences in multiple biologically important phenotypic traits, including drug metabolism and drug response. Of clinical interest, genetic factors affecting narcotic drug withdrawal and susceptibility to fungal infection in transplant patients were also identified using this method.
Dr. Peltz, along with over 150 leading industry executives, will present at the 3rd Modern Drug Discovery & Development Summit. The summit features 6 concurrent conferences, 6 study sessions and 3 workshops. Tracks include Biological Therapeutics, Drug Delivery Technology, Translational Medicine, Drug Design and Lead Optimization, Emerging Targets, and Pharmaco – Kinetics, Dynamics, Genetics & Genomics. For more information, visit www.gtcbio.com.
About GTCbio
GTCbio organizes conferences specifically for the biomedical and biopharmaceutical industries. Their goal is to facilitate the exchange of biopharmaceutical and biomedical intelligence between industry leaders, academic and government organizations, and the financial community.
GTCbio is a subsidiary of Global Technology Community, LLC, a privately held company founded in 2002.
Contact: GTCBIO (626) 256-6405, (626) 256-6460 fax, raniah@gtcbio.com
###
Contact
GTCbio
Rania Hafez
626-256-6405
www.gtcbio.com
Rania Hafez
626-256-6405
www.gtcbio.com
Contact
Categories